Posts Tagged ‘obesity’

The acute shortage of obesity medicines is over. But in absolute terms we are still operating with a mindset of scarcity when thoughts turn to obesity care. Policy often dictates limited access to care and even more so, to medicines that can so effectively treat this condition. What happens if we start thinking in terms […]

When it comes to obesity, it seems everyone is looking for clickbait. Facts are incidental. So this week, we have wildly differing news headlines about U.S. obesity prevalence. The Harvard Gazette tells us we have an “astounding surge” in obesity prevalence. Axios tells us there’s “good news” on obesity prevalence. Where does the truth lie? […]

Honestly, there is so much glaring, blinding irony in the news these days that this one almost slipped by us. Costco makes its money from selling people ginormous packs of food, but now the chain is getting into the action on GLP-1s by selling them at the discounted price of $499 per month. Both Ozempic […]

In the International Journal of Obesity, obesity medicine physician and researcher Caroline Apovian offers a compelling case to favor a prediabetes indication for GLP-1s. She writes: “The approval of a GLP-1 for prediabetes will change the landscape for prevention of T2DM and its complications due to early detection. Currently, most individuals at risk of T2DM […]

Sometime between July 29 and August 27, Leanne Redman became Editor-in-Chief of Obesity, the official journal of the Obesity Society. We know this because the August issue (published July 29) lists Michael Jensen as editor. But the September issue (published August 27) lists Redman as editor. A One-Sided Grievance The only reason this came to […]

In good conscience, it is hard to ignore the steady stream of scientific publications that tell us we are putting our children at risk by filling the world with plastics. And yet it seems that the convenience and ubiquity of plastics make it hard to resist. A sweeping new review in Lancet Child and Adolescent […]

A pair of new papers in the Journal of the American Heart Association serves up a fundamental challenge to assumptions about nutritional guidance in obesity. The science is complex, involving metabolomics and dietary quality. But the concept is simple. Obesity is not just a simple problem of excess body fat. Rather, it is a complex […]

A perverse economic environment is, arguably, propelling us toward an overwhelming health problem with obesity that is becoming a wealth issue. Nick Triggle reports in depth for the BBC and makes a strong case for the idea that advanced obesity medicines are turning obesity into a wealth issue. People with the least wealth have the […]

Back in March 2024, we welcomed the news of a door opening ever so slightly for Medicare Part D plans to cover GLP-1s in people with obesity and heart disease. So 18 months later, it’s reasonable to ask, how’s that working out for everyone? A new research letter in JAMA gives us an answer, but […]

Bimagrumab continues to be a enigma. We see flickering signs of good news – and then, inexplicably, it goes dark. The pattern repeated itself this week when news emerged that Lilly pulled the plug on a phase two study with bimagrumab and tirzepatide in persons with obesity and diabetes before it even enrolled a single […]